Skip to main content
. Author manuscript; available in PMC: 2016 Nov 17.
Published in final edited form as: Neuropsychol Rev. 2012 Apr 13;22(2):195–209. doi: 10.1007/s11065-012-9194-1

Fig. 2.

Fig. 2

Summary of the progression of neuropathology within the thalamus as a function of PTD treatment (based on experimental data from Zhang et al. 1995). Although whether the seizure is a symptom or propagator of glutamate excitotoxicity is debated, it can be used as a time marker for progression of brain pathology